Bluesight
Medication management solutions using RFID technology for accurate restocking, cost savings, and reducing expired medication waste.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Growth Equity VC | |
| Total Funding | 000k | ||
| USD | 2023 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| EV | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Source: Dealroom estimates
Related Content
Bluesight is a healthcare technology company specializing in medication management solutions for hospitals and healthcare providers. The company leverages RFID (Radio Frequency Identification) technology to streamline inventory management, ensuring 100% accurate restocking of medications in critical areas such as crash carts, operating rooms (OR), and auxiliary trays. Bluesight's core products include KitCheck and CostCheck, which optimize drug purchasing, reduce expired medication waste, and provide hard dollar savings by optimizing par levels. The company serves pharmacists and nurses, helping them work more efficiently and safely by providing item-level visibility, workflow simplicity, and actionable analytics. Bluesight operates in the healthcare technology market and generates revenue through the sale of its software solutions and services to healthcare institutions. The business model focuses on empowering customers to reduce costs, risks, and inefficiencies in medication management.
Keywords: RFID, medication management, inventory management, healthcare technology, KitCheck, CostCheck, pharmacists, nurses, cost savings, actionable analytics.
